Literature DB >> 24337666

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle.

A Popa-Wagner1, Ana-Maria Buga, B Popescu, D Muresanu.   

Abstract

To a great extent, cognitive health depends on cerebrovascular health and a deeper understanding of the subtle interactions between cerebrovascular function and cognition is needed to protect humans from one of the most devastating affliction, dementia. However, the underlying biological mechanisms are still not completely clear. Many studies demonstrated that the neurovascular unit is compromised in cerebrovascular diseases and also in other types of dementia. The hemodynamic neurovascular coupling ensures a strong increase of the cerebral blood flow (CBF) and an acute increase in neuronal glucose uptake upon increased neural activity. Dysfunction of cerebral autoregulation with increasing age along with age-related structural and functional alterations in cerebral blood vessels including accumulation of amyloid-beta (Aβ) in the media of cortical arterioles, neurovascular uncoupling due to astrocyte endfeet retraction, impairs the CBF and increases the neuronal degeneration and susceptibility to hypoxia and ischemia. A decreased cerebral glucose metabolism is an early event in Alzheimer's disease (AD) pathology and may precede the neuropathological Aβ deposition associated with AD. Aβ accumulation in turn leads to further decreases in the CBF closing the vicious cycle. Alzheimer, aging and diabetes are also influenced by insulin/insulin-like growth factor-1 signaling, and accumulated evidence indicates sporadic AD is associated with disturbed brain insulin metabolism. Understanding how vascular and metabolic factors interfere with progressive loss of functional neuronal networks becomes essential to develop efficient drugs to prevent cognitive decline in elderly.

Entities:  

Mesh:

Year:  2013        PMID: 24337666     DOI: 10.1007/s00702-013-1129-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  70 in total

1.  Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis.

Authors:  C Marini; R Totaro; F De Santis; I Ciancarelli; M Baldassarre; A Carolei
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

2.  Where vascular meets neurodegenerative disease.

Authors:  Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  The effects of additional pathology on the cognitive deficit in Alzheimer disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; C Joachim; S Litchfield; L Barnetson; A D Smith
Journal:  J Neuropathol Exp Neurol       Date:  1997-02       Impact factor: 3.685

4.  Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.

Authors:  J M Price; X Chi; G Hellermann; E T Sutton
Journal:  Neurol Res       Date:  2001-07       Impact factor: 2.448

Review 5.  Cognitive impairment with vascular impairment and degeneration.

Authors:  Ryszard Pluta; Jukka Jolkkonen; Salvatore Cuzzocrea; Felicita Pedata; David Cechetto; Aurel Popa-Wagner
Journal:  Curr Neurovasc Res       Date:  2011-11       Impact factor: 1.990

Review 6.  Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.

Authors:  Shuko Takeda; Naoyuki Sato; Hiromi Rakugi; Ryuichi Morishita
Journal:  Mol Biosyst       Date:  2011-03-24

7.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

Review 8.  Pathogenesis of cerebral amyloid angiopathy.

Authors:  Annemieke A M Rensink; Robert M W de Waal; Berry Kremer; Marcel M Verbeek
Journal:  Brain Res Brain Res Rev       Date:  2003-10

9.  Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Authors:  Manja Lehmann; Pia M Ghosh; Cindee Madison; Anna Karydas; Giovanni Coppola; James P O'Neil; Yadong Huang; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-21       Impact factor: 10.154

10.  No disease in the brain of a 115-year-old woman.

Authors:  Wilfred F A den Dunnen; Wiebo H Brouwer; Eveline Bijlard; Jeanine Kamphuis; Klaas van Linschoten; Ellie Eggens-Meijer; Gert Holstege
Journal:  Neurobiol Aging       Date:  2008-06-04       Impact factor: 4.673

View more
  50 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 2.  Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide.

Authors:  Noboru Toda; Tomio Okamura
Journal:  Pflugers Arch       Date:  2016-07-14       Impact factor: 3.657

3.  miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion.

Authors:  Xiaowen Zhang; Xiongweiye Huang; Chen Fang; Qian Li; Jing Cui; Jing Sun; Liang Li
Journal:  Mol Neurobiol       Date:  2016-03-16       Impact factor: 5.590

Review 4.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 5.  Astrocyte and Alzheimer's disease.

Authors:  Zhiyou Cai; Cheng-Qun Wan; Zhou Liu
Journal:  J Neurol       Date:  2017-08-18       Impact factor: 4.849

6.  Stimulus-evoked changes in cerebral vessel diameter: A study in healthy humans.

Authors:  Alexandre Bizeau; Guillaume Gilbert; Michaël Bernier; Minh Tung Huynh; Christian Bocti; Maxime Descoteaux; Kevin Whittingstall
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-31       Impact factor: 6.200

Review 7.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

8.  Calmodulin inhibitor ameliorates cognitive dysfunction via inhibiting nitrosative stress and NLRP3 signaling in mice with bilateral carotid artery stenosis.

Authors:  Rui Wang; Yi-Xuan Yin; Qaisar Mahmood; Xiao-Juan Wang; Yin-Ping Gao; Guo-Jing Gou; Muhammad Masood Ahmed; Fukunag Kohji; Yong-Zhong Du; Feng Han
Journal:  CNS Neurosci Ther       Date:  2017-08-28       Impact factor: 5.243

9.  Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities.

Authors:  Dazhi Duan; Congyang Li; Lin Shen; Chun Cui; Tongsheng Shu; Jian Zheng
Journal:  Front Aging Neurosci       Date:  2016-09-07       Impact factor: 5.750

10.  Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation.

Authors:  Amandine Jullienne; Jill M Roberts; Viorela Pop; M Paul Murphy; Elizabeth Head; Gregory J Bix; Jérôme Badaut
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.